Expression of concern
Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway
Paper Information
Record ID:
32792
Author(s):
Journal:
Publication Date:
September 11, 2003
Retraction Date:
October 01, 2021
(4.1 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1038/s41388-021-02034-7Additional Notes:
see also: https://pubpeer.com/publications/5CEEC0DDB3631056C3806AD7D9D341;
Citations (71)
71
Total Citations8
Post-Retraction(11.3%)
62
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
5
After 2+ years
1155
Days since retraction (latest)
Interleukin‐4 activates androgen receptor through CBP/p300
Soo Ok Lee, Jae Yeon Chun, Nagalakshmi Nadiminty et al. (6 authors)
The Prostate
Open Access
Published: Sep 2008
31 citations
31 citations
4754 days before retraction
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
Angela Seaton, P. Scullin, Perry Maxwell et al. (9 authors)
Carcinogenesis
Open Access
Published: Apr 2008
142 citations
142 citations
4917 days before retraction
Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancers
Qingan Zhu, Hyewon Youn, Jiajun Tang et al. (10 authors)
Oncogene
Open Access
Published: Mar 2008
78 citations
78 citations
4932 days before retraction
Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer
Yosra Bouraoui, Mónica Ricote, Ignacio García‐Tuñón et al. (10 authors)
Cancer Detection and Prevention
Published: Jan 2008
71 citations
71 citations
5022 days before retraction
Interleukin‐4 stimulates androgen‐independent growth in LNCaP human prostate cancer cells
Soo Ok Lee, Elaine Pinder, Jae Yeon Chun et al. (6 authors)
The Prostate
Open Access
Published: Nov 2007
46 citations
46 citations
5069 days before retraction
Androgen Receptor Function in Prostate Cancer Progression
Helmut Klocker, Iris E. Eder, Barbara Comuzzi et al. (5 authors)
Humana Press eBooks
Open Access
Published: Nov 2007
7 citations
7 citations
5075 days before retraction
Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival
Ilanchezian Shanmugam, Guanxun Cheng, Paul F. Terranova et al. (6 authors)
Cell Death and Differentiation
Open Access
Published: Oct 2007
63 citations
63 citations
5103 days before retraction
Interleukin-4/13 and Cancer
Koji Kawakami, Raj K. Puri
Humana Press eBooks
Published: Sep 2007
5127 days before retraction
Paper citing Interleukin-4 enhances prostate-specific antigen e...
Unknown Authors
Unknown Journal
Published: Sep 2007
5144 days before retraction
Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells
Soo‐Yeon Park, Yun Jeong Kim, Allen C. Gao et al. (10 authors)
Cancer Research
Published: May 2006
78 citations
78 citations
5618 days before retraction
Regulatory processes affecting androgen receptor expression, stability, and function: Potential targets to treat hormone‐refractory prostate cancer
G. Prem Veer Reddy, Evelyn Barrack, Q. Ping Dou et al. (7 authors)
Journal of Cellular Biochemistry
Published: Apr 2006
79 citations
79 citations
5646 days before retraction
Autocrine Production of Interleukin-4 and Interleukin-10 Is Required for Survival and Growth of Thyroid Cancer Cells
Matilde Todaro, M Zerilli, Lucia Ricci‐Vitiani et al. (12 authors)
Cancer Research
Published: Feb 2006
126 citations
126 citations
5721 days before retraction
Interleukin-4 in patients with prostate cancer.
Takeshi Ueda, Marianne D. Sadar, Hiroyoshi Suzuki et al. (11 authors)
PubMed
Published: Dec 2005
32 citations
32 citations
5771 days before retraction
Inhibition of the Akt, cyclooxygenase‐2, and matrix metalloproteinase‐9 pathways in combination with androgen deprivation therapy: Potential therapeutic approaches for prostate cancer
Hiroshi Miyamoto, Saleh Altuwaijri, Yi Cai et al. (5 authors)
Molecular Carcinogenesis
Published: Jul 2005
67 citations
67 citations
5912 days before retraction
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
Zoran Čulig, Hannes Steiner, G. Bartsch et al. (4 authors)
Endocrine Related Cancer
Open Access
Published: Jun 2005
95 citations
95 citations
5966 days before retraction
Molecular markers of prostate cancer outcome
David I. Quinn, Susan M. Henshall, Robert L. Sutherland
European Journal of Cancer
Published: Apr 2005
192 citations
192 citations
6027 days before retraction
Requirement for NF-κB in interleukin-4-induced androgen receptor activation in prostate cancer cells
Soo Ok Lee, Wei Lou, Nagalakshmi Nadiminty et al. (5 authors)
The Prostate
Published: Jan 2005
61 citations
61 citations
6091 days before retraction
Regulation of androgen receptor signaling in prostate cancer
Scott M. Dehm, Donald J. Tindall
Expert Review of Anticancer Therapy
Published: Jan 2005
89 citations
89 citations
6117 days before retraction
Hormonal Influences on Cancer Progression and Prognosis
Gajanan V. Sherbet
Vitamins and hormones
Published: Jan 2005
11 citations
11 citations
6117 days before retraction
Molecular and cellular prostate biology: origin of prostate‐specific antigen expression and implications for benign prostatic hyperplasia
Jack A. Schalken
BJU International
Published: Feb 2004
25 citations
25 citations
6436 days before retraction
Androgen Receptor Cross-talk with Cell Signalling Pathways
Zoran Čulig
Growth Factors
Published: Jan 2004
139 citations
139 citations
6483 days before retraction
Quick Stats
Total Citations:
71
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025